INTRODUCTION
To explore the potential of an adenoviral antisense RNA transcript for gene therapy of cervical cancer, we introduced the anti-
The most important risk factor for cervical cancer is husense RNA transcript of E6 and E7 genes of human papillomavirus man papillomavirus (HPV) infection, which has been shown cohort studies by 11-to 60-fold [1] . HPV has been identified growth. Ad5CMV-HPV 16 AS contains the cytomegalovirus-proin up to 90% of cervical cancers, and 60% of these are HPV moter, E6 and E7 genes of HPV 16 in antisense orientation, and the SV40 polyadenylation signal in a mini-gene cassette, which is 16 [2] . The viral DNA is usually integrated into host DNA, inserted into the E1-deleted region of modified adenovirus 5. The and HPV-specific RNA and proteins can be detected in the entire E6/E7 region of HPV 16 was amplified by polymerase chain tumors and cell lines derived from them [3] . Inactivation of reaction (PCR) before cloning into the mini-gene cassette. By re-the p53 gene by allelic loss or by point mutation is infrequent verse transcriptase-PCR, HPV 16 E6/E7 antisense RNA was de-in primary cervical cancer, and the overall incidence of p53 tected in SiHa cells infected with Ad5CMV-HPV 16 AS. The point mutations in these cancers is 1-6% [4] .
growth of the Ad5CMV-HPV 16 AS-infected cells was greatly
The role of HPV in the pathogenesis of human cancers These data suggest that transfection of cervical cancer cells with promote p53 degradation [5] . HPV-positive cell lines ex-HPV 16 E6/E7 antisense RNA in a form such as Ad5CMV-HPV press low levels of wild-type p53 [6] . The E7 protein binds 16 AS is a potential novel approach to the therapy of HPV 16-to the Rb protein, preventing Rb from binding to its normal positive cervical cancer. ᭧ 1996 Academic Press, Inc.
substrate, the E2F-1 protein [7] . The E6 and E7 proteins of HPV 16 and 18 have been demonstrated to be necessary to efficiently immortalize their natural host cells, primary Presented at the 27th Annual Meeting of the Society of Gynecologic human squamous epithelial cells [8] . Howley and colOncologists, New Orleans, LA, February 10- 14, 1996. leagues have demonstrated that the inactivation of Rb and 1 This study was partially supported by a grant from the National Cancer p53 are important steps in cervical carcinogenesis [6] . FurInstitute (RO1 CA45187) [J.A.R.]; by gifts to the Division of Surgery from thermore, the continued expression of the E6 and E7 re- to the possibility of using antisense RNA to develop gene straints of the adenovirus capsid. An adenoviral vector containing the same cassette but without the HPV 16 E6/E7 therapy techniques for human carcinomas that contain HPV DNA. Steele et al. [11] showed that a plasmid that expressed cDNA was used as the control (Ad5CMV-poly(A) ). An adenoviral vector containing the same cassette but with p53 antisense RNA of HPV 18 decreased the growth rate of the human cervical cancer cell line HeLa, but the low transduc-cDNA (Ad5CMV-p53) was also used to study the growth inhibitory effects. tion efficiency of the plasmid in the cell is problematic. Antisense E6 and E7 oligonucleotides have been shown to Adenoviral Infection inhibit the growth of HPV-positive cancer cells but not HPVnegative cells [12] . However, when the oligonucleotides Recombinant adenovirus was purified by double cesium were withdrawn after 3 days of culture, the remaining cells gradient ultracentrifugation as described elsewhere [14] . Virecovered and grew as before. Any therapy with oligonucleo-ral stocks were propagated in 293 cells. Cells were harvested tides might therefore require continuous administration.
36-40 hr after infection and cell debris was removed by Adenoviral vectors have many advantages over other viral subjecting the lysed cells to CsCl gradient centrifugation. vector systems and other in vitro techniques for introducing Concentrated virus was dialyzed and stored in aliquots at DNA into eukaryotic cells. However, there have been no 080ЊC. Infection was carried out by adding the virus to reports of the efficacy of an adenoviral construct of antisense high-glucose Dulbecco's modified Eagle's medium and to HPV E6 and E7. In the study presented here, the E6/E7 the cell monolayers. The viral titers were determined by region of HPV 16 in the antisense orientation was inserted plaque assays [14] . into an adenoviral vector. 
Reverse transcriptase (RT)-PCR was per-MATERIALS AND METHODS
formed from 6 mg of total RNA to generate cDNA. These cDNA products were then amplified by PCR, using primers Cell Lines and Culture Conditions for the antisense E6/E7 of HPV 16 and the poly(A) signal The human cervical cancer cell line SiHa was obtained of the adenovirus, yielding a 486-bp product. PCR products from the American Type Culture Collection (Rockville, were analyzed on 2% agarose gels and stained with ethidium MD). SiHa is an HPV 16-positive cell line and has a wild-bromide. type p53 [13] . Cells were grown in RPMI medium supplemented with 10% heat-inactivated fetal bovine serum.
Cell Count Assay
Recombinant Adenovirus
Cells were plated at a density of 5 1 10 4 /well in 12-well plates in triplicate. RPMI supplemented with 10% heatThe HPV 16 genome, cloned into PBR322, was provided inactivated fetal bovine serum was used as the growth meby the Japanese Cancer Research Resources Bank (JCRB, dium. Cells were infected with either Ad5CMV-HPV 16 Tokyo). The entire E6/E7 region (nt 45 to 877) was amplified AS or the Ad5CMV-poly(A) control at a multiplicity of by polymerase chain reaction (PCR) using an upstream infection (m.o.i., viral particles per cell) of 100. Culture primer with a NotI site and a downstream primer with a medium was used for mock infection. Triplicate cultures of HindIII site. This fragment was cloned in the antisense orien-SiHa cells with different treatments were analyzed. Cells tation into pAdE1CMV, a shuttle plasmid that contains the were harvested by trypsinization and counted daily for 6 left end of Ad5 (0-16 map units, m.u.) with an E1 region days. Cell viability was determined by trypan blue exclusion (1.25-9.2 m.u.) substituted by an expression cassette con-after harvest. taining the cytomegalovirus (CMV) promoter, a multicloning site, and a simian virus (SV40) polyadenylation signal. [ 3 H]Thymidine Incorporation Assay The recombinant plasmid with the E6/E7 region was cotransfected with pJM17 into 293 cells which are derived from Cells were cultured at 2 1 10 3 cells/well in 96-well flatbottomed plates. Cells were infected with Ad5CMV-p53, primary embryonal kidney cells transformed by introducing sheared fragments of Ad5 DNA. This cell line contains an Ad5CMV-HPV 16 AS, or Ad5CMV-poly(A) and cultured in medium for 5 days. Each well was pulse-treated with 1 integrated E1 region and is thus highly permissive of the replication of the E1 replication-deficient adenovirus. A plas-mCi [ 3 H]thymidine (sp act, 6.7 Ci/mmol; Amersham Inc., Arlington Heights, IL) for an additional 24 hr, after which mid, pJM17 contains the entire Ad5 DNA molecule, with an insert in the E1 region that exceeds the packaging con-the cells were harvested with a Ph.D. cell harvester (Cam-bridge Technology, Cambridge, MA). Individual filter discs The growth inhibitory effect of Ad5CMV-HPV 16 AS was greatly enhanced by the combining that vector with were then processed for liquid scintillation counting. The data are presented as the means of triplicate samples.
Ad5CMV-p53 (Figs. 4 and 5 hours after infection, the treated cells were harvested and SiHa cells treated with medium alone were used as mockrinsed twice with phosphate-buffered saline (PBS). For each infected controls. Tumors were formed only from the treatment, 10 million (1 1 10 7 ) cells in a volume of 0.1 ml mock-or control virus-infected cells; mice that received were injected subcutaneously into each nude (nu/nu) female Ad5CMV -HPV 16 AS-treated cells did not develop tumouse (aged 4-5 weeks; Harlan Co., Houston, TX). Ten mors (Table 1 ). This study was initiated with 10 mice per mice were used for each treatment. The mice were examined group and was completed in all. every day and tumor formation and size were evaluated for 44 days. The tumors were measured every other day with DISCUSSION calipers in two perpendicular diameters without knowledge of treatment groups. Tumor volume was calculated by assuming a spherical shape with the average tumor diameter Recombinant adenovirus is a gene delivery system that calculated as the square root of the product of cross-sectional has great potential for cancer gene therapy. In this study, a diameters.
recombinant adenovirus that expresses the antisense HPV E6/E7 gene was generated. The virus, Ad5CMV-HPV 16 RESULTS AS, contains the CMV promoter, the total sequence of HPV 16 E6/E7 in the antisense orientation, and the SV40 polyadenylation signal. PCR assays and sequencing analysis of puriThe entire E6/E7 region was amplified and cloned in antisense orientation into the shuttle plasmid vector to form the fied adenovirus DNA showed that Ad5CMV-HPV 16 AS was the newly generated recombinant adenovirus. RT-PCR plasmid pAdE1CMV-HPV 16 AS. The expected genomic structure of Ad5CMV-HPV 16 AS is depicted in Fig. 1B . analysis also showed that Ad5CMV-HPV 16 AS expressed the RNA of antisense HPV E6/E7 in the Ad5CMV-HPV Figure 1C shows that a 0.49-kb HPV 16 E6/E7 antisensespecific band and a 0.33-kb adenovirus-specific band ampli-16 AS-infected SiHa cells. Expression of E6 and E7 genes has been linked directly to the proliferative capacity of cervified through PCR confirmed the identity of Ad5CMV-HPV 16 AS. This was further verified by sequencing analysis of cal cancer cells and is also required for the maintenance of the transformed phenotype [15, 16] . Because most cervical the CsCl gradient-purified Ad5CMV-HPV 16 AS DNA. In RT-PCR analysis, the transcript of antisense E6/E7 RNA carcinomas contain the transforming E6 and E7 genes, these genes make an attractive target for antisense inhibition. It from Ad5CMV-HPV 16 AS was detected in Ad5CMV-HPV 16 AS-infected SiHa cells, while Ad5CMV-poly(A)-was shown that HPV 16-or 18-positive cervical cancer cells were inhibited by oligonucleotides [12, 17] and plasmids [9, infected cells and mock-infected cells did not show any adenoviral antisense transcripts (Fig. 2) . 11] that expressed RNA antisense to the transforming genes E6 and E7 of HPV. However, there have been no reports of The SiHa cells were treated with Ad5CMV-HPV 16 AS, Ad5CMV-poly(A), or medium only. In cell count assay, the growth of cervical cancer cells being inhibited in vitro or in vivo by viral vectors expressing the antisense RNA of the growth of the Ad5CMV-HPV 16 AS-infected SiHa cells was greatly suppressed (Fig. 3) . Taking the growth inhibition these genes. In the study presented here, we used an adenoviral vector because adenovirus has the feature of high infecof the mock-infected SiHa cells as 0% on Day 6, that of Ad5CMV-HPV 16 AS-infected cells was 96%. The cells tivity in eukaryotic cells.
We examined the effects of Ad5CMV-HPV 16 AS in infected with Ad5CMV-poly(A) had a growth rate similar to that of the mock-infected cells. This growth assay was cervical cancer SiHa cells in culture and in tumors in nude mice. The results clearly demonstrate the effectiveness of reproducible in five repeated experiments.
The growth inhibitory effect of Ad5CMV-HPV 16 AS the anti-HPV 16 E6/E7 adenoviral vector. The antisense HPV E6/E7 plasmid and the oligonucleotides anti-E6 plus was compared with that of an adenoviral p53 vector, Ad5CMV-p53. In [ 3 H]thymidine incorporation assay, m.o.i. anti-E7 lead to greater inhibition of growth of HPV-positive cells than the antisense HPV E7 plasmid or the anti-E7 oligoat the 50% growth inhibitory effect (IC 50 ) of Ad5CMV-HPV 16 AS was similar to that of Ad5CMV-p53 (Fig. 5) . nucleotides [11, 17] . The effect of antisense E6 and E7 is 
FIG. 1-Continued
probably due to a reversal of the transformed phenotype ated with the suppression of E7 expression and the antisense HPV E6 probably exerts its effect through the suppression brought about by the inhibition of E6 and E7.
The effects of antisense HPV E7 on cell growth are associ-of E6 as well as E7 [16] . In cervical cancers and cervical cancer cell lines containing HPV, mRNAs encoding the E6 and E7 proteins are transcribed from the same promoter in the form of a bicistronic transcript [18] . The bicistronic transcript is also spliced to produce two shorter transcripts E6 I-E7 and E6 II-E7 [19] . It has been proposed that it is a function of these spliced transcripts to stimulate E7 translation [18] . E7 protein is known to bind the product of the retinoblastoma susceptibility gene, Rb, thereby preventing pRb from regulating cell growth [20] . Inhibition of E7 protein expression allows pRb to perform its function of regulating cell growth [21] . E7 can directly interfere with cell cycle control by inducing S-phase entry by sequential activation of cyclin A gene and cyclin E gene expression [22] . Both E6 and E7 play important roles in affecting specific, though distinct check point controls in G 1 [23, 24] . It has been forming activity of E6 is localized to the carboxy terminal region of the protein [23] . It has also been reported that and Rb-dependent pathway or the p53-and Rb-independent pathway. anti-E7 oligonucleotides decrease E7 protein expression and increase Rb protein expression [17] . Because the changes in Some RNA molecules can act as enzymes to cleave other RNA molecules at specific sites [25] . One type of these RNA E6 and E7 mRNA and protein expression were not determined in this study, further experiments should address enzymes or ribozymes that has been studied in detail is the hammerhead ribozyme. Any RNA molecule can be targeted whether the mechanism of the growth inhibition of HPV 16-positive cells by Ad5CMV-HPV 16 AS is due to the p53-for cleavage by base pairing with a second RNA that is 
, and yet HPV 18 E6 is more efficient in the ras cooperation assay [23] . In addition, continuous E6 and E7 protein expression is required to maintain the malignant phenotype of these cells [23] . The adenoviral vector is capable of mediating high levels of antisense RNA expression that apparently are sufficient to overcome the capabilities of endogenous E6 and E7 protein expression. Restoration of p53 and Rb function, and inhibition of p53-and Rb-independent pathway by Ad5CMV-HPV 16 AS might be effective in reducing proliferation of these cells.
In this study, first-generation viruses from which E1A and E1B were deleted were used in vitro and ex vivo experiments. This adenovirus-mediated transgene expression in immunocompetent mice was transient and significantly reduced following a second administration of the virus 4 weeks after an initial injection [28] . Expression levels of the FIX gene with adenovirus vector declined to base level by 9 weeks and were not reestablished by a second injection 10 weeks after the initial injection [29] . To overcome these problems These experiments demonstrated that the recombinant adenoviral vector Ad5CMV-HPV 16 AS can be used as an designed to form a hammerhead structure. An inhibitory effect more potent than that produced by complementary efficient gene delivery vehicle for treatment of cervical cancer. A treatment strategy based on disruption or inhibition antisense transcripts and oligonucleotides might be obtained by hammerhead ribozymes because such molecules not only of oncogene expression might be effective as an adjuvant treatment to prevent local recurrence following primary tubind to the target transcript but also can cleave it at a specific site [25] . Indeed, hammerhead ribozymes can bind and mor resection or as a treatment that could be given by intralesional injections in primary, metastatic, or locally recurcleave RNA transcripts derived from the E6 and E7 genes of human papillomavirus type 16 and 18 [25, 26] , can inhibit rent cancers. We have already reported that growth of intradermal tumor and raft culture of cervical cancer cell line was the replication of HPV virus, and can reverse the malignant phenotype of cells that express the ras oncogene [27] . How-markedly reduced by Ad5CMV-p53 [30] . In preinvasive disease, HPV DNA is not integrated into the host chromoever, studies comparing the two are necessary because ribozymes are not always more effective than antisense mole-somes and E6/E7 oncoproteins are predominant in cell cules. Therefore, tests to evaluate the antitumor potential of 
